{"entity":{"type":"insider","cik":"0001863676","url":"/insider/0001863676","json_url":"/insider/0001863676.json","name":"Blackman Samuel C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":35,"first":"2021-12-03","last":"2024-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Blackman Samuel C.","source":"filing","n_filings":35,"first_seen":"2021-12-03","last_seen":"2024-12-12"}],"transactions":[{"id":2663015,"accession":"0001415889-24-029085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029085","line_url":"/filing/0001415889-24-029085#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":13.3113,"price_display":"13.31","price_state":"stated","total_value":399339.0,"total_display":"399,339.00","total_whole":"399,339","shares_owned_after":1034015.0,"shares_owned_after_display":"1,034,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider"},{"id":3001157,"accession":"0001415889-24-027234","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027234","line_url":"/filing/0001415889-24-027234#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2206.0,"shares_display":"2,206","price_per_share":13.2102,"price_display":"13.21","price_state":"stated","total_value":29141.7012,"total_display":"29,141.70","total_whole":"29,142","shares_owned_after":1064015.0,"shares_owned_after_display":"1,064,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2257433,"accession":"0001415889-24-026624","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026624","line_url":"/filing/0001415889-24-026624#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.0994,"price_display":"16.10","price_state":"stated","total_value":160994.0,"total_display":"160,994.00","total_whole":"160,994","shares_owned_after":1057535.0,"shares_owned_after_display":"1,057,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-12","scope":"insider"},{"id":2257430,"accession":"0001415889-24-026624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026624","line_url":"/filing/0001415889-24-026624#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18255.0,"shares_display":"18,255","price_per_share":16.1725,"price_display":"16.17","price_state":"stated","total_value":295228.9875,"total_display":"295,228.99","total_whole":"295,229","shares_owned_after":1067535.0,"shares_owned_after_display":"1,067,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2807515,"accession":"0001415889-24-026434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026434","line_url":"/filing/0001415889-24-026434#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11245.0,"shares_display":"11,245","price_per_share":16.0326,"price_display":"16.03","price_state":"stated","total_value":180286.587,"total_display":"180,286.59","total_whole":"180,287","shares_owned_after":1085790.0,"shares_owned_after_display":"1,085,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-08","scope":"insider"},{"id":2449082,"accession":"0001415889-24-026036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026036","line_url":"/filing/0001415889-24-026036#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":16.02,"price_display":"16.02","price_state":"stated","total_value":8010.0,"total_display":"8,010.00","total_whole":"8,010","shares_owned_after":1097035.0,"shares_owned_after_display":"1,097,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-31","filed_date":"2024-11-04","scope":"insider"},{"id":2257085,"accession":"0001415889-24-023298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023298","line_url":"/filing/0001415889-24-023298#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":14.2225,"price_display":"14.22","price_state":"stated","total_value":426675.0,"total_display":"426,675.00","total_whole":"426,675","shares_owned_after":1097535.0,"shares_owned_after_display":"1,097,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":3086633,"accession":"0001415889-24-021621","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-021621","line_url":"/filing/0001415889-24-021621#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2232.0,"shares_display":"2,232","price_per_share":13.9991,"price_display":"14.00","price_state":"stated","total_value":31245.9912,"total_display":"31,245.99","total_whole":"31,246","shares_owned_after":1127535.0,"shares_owned_after_display":"1,127,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":2530451,"accession":"0001415889-24-019681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019681","line_url":"/filing/0001415889-24-019681#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.0113,"price_display":"16.01","price_state":"stated","total_value":320226.0,"total_display":"320,226.00","total_whole":"320,226","shares_owned_after":1121081.0,"shares_owned_after_display":"1,121,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-17","scope":"insider"},{"id":2530309,"accession":"0001415889-24-016507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-016507","line_url":"/filing/0001415889-24-016507#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.6196,"price_display":"12.62","price_state":"stated","total_value":378588.0,"total_display":"378,588.00","total_whole":"378,588","shares_owned_after":1141081.0,"shares_owned_after_display":"1,141,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-12","scope":"insider"},{"id":2863016,"accession":"0001415889-24-013618","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-013618","line_url":"/filing/0001415889-24-013618#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2267.0,"shares_display":"2,267","price_per_share":16.0787,"price_display":"16.08","price_state":"stated","total_value":36450.4129,"total_display":"36,450.41","total_whole":"36,450","shares_owned_after":1171081.0,"shares_owned_after_display":"1,171,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2222386,"accession":"0001415889-24-013159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-013159","line_url":"/filing/0001415889-24-013159#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.3743,"price_display":"16.37","price_state":"stated","total_value":163743.0,"total_display":"163,743.00","total_whole":"163,743","shares_owned_after":1164662.0,"shares_owned_after_display":"1,164,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-14","scope":"insider"},{"id":3176631,"accession":"0001415889-24-011332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-011332","line_url":"/filing/0001415889-24-011332#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.0163,"price_display":"16.02","price_state":"stated","total_value":160163.0,"total_display":"160,163.00","total_whole":"160,163","shares_owned_after":1174662.0,"shares_owned_after_display":"1,174,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-18","filed_date":"2024-04-22","scope":"insider"},{"id":3141235,"accession":"0001415889-24-009146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009146","line_url":"/filing/0001415889-24-009146#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.0055,"price_display":"16.01","price_state":"stated","total_value":160055.0,"total_display":"160,055.00","total_whole":"160,055","shares_owned_after":1184662.0,"shares_owned_after_display":"1,184,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-26","scope":"insider"},{"id":3252300,"accession":"0001415889-24-007810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007810","line_url":"/filing/0001415889-24-007810#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.2438,"price_display":"15.24","price_state":"stated","total_value":457314.0,"total_display":"457,314.00","total_whole":"457,314","shares_owned_after":1194662.0,"shares_owned_after_display":"1,194,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider"},{"id":2039540,"accession":"0001415889-24-005787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-005787","line_url":"/filing/0001415889-24-005787#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF R&D)","role_mark":"O","role_mark_label":"Officer (HEAD OF R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.1083,"price_display":"16.11","price_state":"stated","total_value":322166.0,"total_display":"322,166.00","total_whole":"322,166","shares_owned_after":1224662.0,"shares_owned_after_display":"1,224,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-28","scope":"insider"},{"id":2659166,"accession":"0001415889-24-004459","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-004459","line_url":"/filing/0001415889-24-004459#line-4","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (HEAD OF RESEARCH AND DEVELOPME)","role_mark":"O","role_mark_label":"Officer (HEAD OF RESEARCH AND DEVELOPME)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RESEARCH AND DEVELOPME","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2258.0,"shares_display":"2,258","price_per_share":15.2481,"price_display":"15.25","price_state":"stated","total_value":34430.2098,"total_display":"34,430.21","total_whole":"34,430","shares_owned_after":1244662.0,"shares_owned_after_display":"1,244,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":8405871,"accession":"0001209191-23-055884","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-055884","line_url":"/filing/0001209191-23-055884#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Head of Research and Developme)","role_mark":"O","role_mark_label":"Officer (Head of Research and Developme)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Research and Developme","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":709.0,"shares_display":"709","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":8288.21,"total_display":"8,288.21","total_whole":"8,288","shares_owned_after":1238234.0,"shares_owned_after_display":"1,238,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8404890,"accession":"0001209191-23-046418","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046418","line_url":"/filing/0001209191-23-046418#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Head of Research and Developme)","role_mark":"O","role_mark_label":"Officer (Head of Research and Developme)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Head of Research and Developme","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":668.0,"shares_display":"668","price_per_share":13.86,"price_display":"13.86","price_state":"stated","total_value":9258.48,"total_display":"9,258.48","total_whole":"9,258","shares_owned_after":1236319.0,"shares_owned_after_display":"1,236,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-17","scope":"insider"},{"id":7835560,"accession":"0001209191-23-035128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035128","line_url":"/filing/0001209191-23-035128#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1229.0,"shares_display":"1,229","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":19664.0,"total_display":"19,664.00","total_whole":"19,664","shares_owned_after":1234363.0,"shares_owned_after_display":"1,234,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8332926,"accession":"0001209191-23-030392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-030392","line_url":"/filing/0001209191-23-030392#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":692.0,"shares_display":"692","price_per_share":13.1223,"price_display":"13.12","price_state":"stated","total_value":9080.6316,"total_display":"9,080.63","total_whole":"9,081","shares_owned_after":1235592.0,"shares_owned_after_display":"1,235,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8364927,"accession":"0001209191-23-018617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018617","line_url":"/filing/0001209191-23-018617#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.0484,"price_display":"18.05","price_state":"stated","total_value":180484.0,"total_display":"180,484.00","total_whole":"180,484","shares_owned_after":1233660.0,"shares_owned_after_display":"1,233,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-14","scope":"insider"},{"id":8035071,"accession":"0001209191-23-010812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-010812","line_url":"/filing/0001209191-23-010812#line-3","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":674.0,"shares_display":"674","price_per_share":19.573,"price_display":"19.57","price_state":"stated","total_value":13192.202,"total_display":"13,192.20","total_whole":"13,192","shares_owned_after":1243660.0,"shares_owned_after_display":"1,243,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8105193,"accession":"0001209191-23-008862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-008862","line_url":"/filing/0001209191-23-008862#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0659,"price_display":"20.07","price_state":"stated","total_value":200659.0,"total_display":"200,659.00","total_whole":"200,659","shares_owned_after":1241710.0,"shares_owned_after_display":"1,241,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-13","scope":"insider"},{"id":8572901,"accession":"0001209191-23-003020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003020","line_url":"/filing/0001209191-23-003020","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.864375,"price_display":"22.86","price_state":"stated","total_value":228643.75,"total_display":"228,643.75","total_whole":"228,644","shares_owned_after":1252648.0,"shares_owned_after_display":"1,252,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider","n_lines":2},{"id":6614136,"accession":"0001209191-22-059716","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-059716","line_url":"/filing/0001209191-22-059716","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.452989,"price_display":"21.45","price_state":"stated","total_value":214529.89,"total_display":"214,529.89","total_whole":"214,530","shares_owned_after":1261048.0,"shares_owned_after_display":"1,261,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider","n_lines":2},{"id":6575017,"accession":"0001209191-22-057639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-057639","line_url":"/filing/0001209191-22-057639#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":377.0,"shares_display":"377","price_per_share":21.4598,"price_display":"21.46","price_state":"stated","total_value":8090.3446,"total_display":"8,090.34","total_whole":"8,090","shares_owned_after":1270148.0,"shares_owned_after_display":"1,270,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":6374772,"accession":"0001209191-22-055577","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055577","line_url":"/filing/0001209191-22-055577#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.005,"price_display":"20.00","price_state":"stated","total_value":200050.0,"total_display":"200,050.00","total_whole":"200,050","shares_owned_after":1269338.0,"shares_owned_after_display":"1,269,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6729991,"accession":"0001209191-22-052747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052747","line_url":"/filing/0001209191-22-052747#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.9852,"price_display":"19.99","price_state":"stated","total_value":199852.0,"total_display":"199,852.00","total_whole":"199,852","shares_owned_after":1279338.0,"shares_owned_after_display":"1,279,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6517698,"accession":"0001209191-22-048898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048898","line_url":"/filing/0001209191-22-048898","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.24515047,"price_display":"23.25","price_state":"stated","total_value":232451.5047,"total_display":"232,451.50","total_whole":"232,452","shares_owned_after":1290927.0,"shares_owned_after_display":"1,290,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":6149388,"accession":"0001209191-22-046484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046484","line_url":"/filing/0001209191-22-046484#line-2","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":941.0,"shares_display":"941","price_per_share":24.31,"price_display":"24.31","price_state":"stated","total_value":22875.71,"total_display":"22,875.71","total_whole":"22,876","shares_owned_after":1299338.0,"shares_owned_after_display":"1,299,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":6729278,"accession":"0001209191-22-044325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044325","line_url":"/filing/0001209191-22-044325#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.881,"price_display":"16.88","price_state":"stated","total_value":168810.0,"total_display":"168,810.00","total_whole":"168,810","shares_owned_after":1296718.0,"shares_owned_after_display":"1,296,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6352792,"accession":"0001209191-22-041407","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-041407","line_url":"/filing/0001209191-22-041407","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.71580864,"price_display":"18.72","price_state":"stated","total_value":187158.0864,"total_display":"187,158.09","total_whole":"187,158","shares_owned_after":1310894.0,"shares_owned_after_display":"1,310,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider","n_lines":3},{"id":6211090,"accession":"0001209191-22-038229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038229","line_url":"/filing/0001209191-22-038229#line-1","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.2631,"price_display":"16.26","price_state":"stated","total_value":813155.0,"total_display":"813,155.00","total_whole":"813,155","shares_owned_after":1316718.0,"shares_owned_after_display":"1,316,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-17","scope":"insider"},{"id":6541130,"accession":"0001209191-22-002026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002026","line_url":"/filing/0001209191-22-002026","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.10178608,"price_display":"17.10","price_state":"stated","total_value":171017.8608,"total_display":"171,017.86","total_whole":"171,018","shares_owned_after":1370046.0,"shares_owned_after_display":"1,370,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider","n_lines":2},{"id":4288652,"accession":"0001209191-21-068000","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-068000","line_url":"/filing/0001209191-21-068000","is_derivative":false,"issuer_cik":"0001845337","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001845337","owner_cik":"0001863676","owner_name":"Blackman Samuel C.","owner_display_name":"Blackman Samuel C.","owner_url":"/insider/0001863676","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.22421589,"price_display":"17.22","price_state":"stated","total_value":172242.1589,"total_display":"172,242.16","total_whole":"172,242","shares_owned_after":1381629.0,"shares_owned_after_display":"1,381,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Officer (HEAD OF R&D)","n_filings":35,"first_seen":"2021-12-03","last_seen":"2024-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001863676","retrieved_at":"2026-08-23T02:39:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}